Drugs / LipoCol Forte
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01527669 | Feb 2012 | — | National Taiwan University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01269762 | Jan → Apr 2011 | — | National Taiwan University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LipoCol Forte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01269762 ↗ |
| Route | Oral | “single oral administration” NCT01527669 ↗ |